Parexel
Also known as: Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa) | Bloemfontein Early Phase Clinical Unit, PAREXEL Internation (South Africa) | California Clinical Trials Medical Group, a division of PAREXEL International | California Clinical Trials Medical Group (CCTMG) managed by Parexel | California Clinical Trials Medical Group - PAREXEL, Early Phase Clinical Unit-Los Angeles | CCT/Parexel | Early Phase Clinical Unit (EPCU) PAREXEL International GmbH | Early Phase Clinical Unit, PAREXEL International GmbH, Berlin | Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site) | Farmovs-Parexel, Bloemfontein, RSA | Farmovs-Parexel Clinical Research Organization | Glendale Parexel Early Phase Clinical Unit | Institute of Pharmacology Parexel International GmbH, Spandauer Damm 130, Haus 31, 14050 Berlin, Germany | Paraxel International | Parexel | Parexel Baltimore Early Phase Clinical Unit | Parexel Berlin | Parexel, Berlin, Germany | PAREXEL/CCT Early Phase Clinical Unit | PAREXEL Clinical Pharmacology Research Unit | PAREXEL Clinical Pharmacology Research Unit at Baltimore, MD | PAREXEL Clinical Pharmacology Research Unit Harbor Hospital Center | PAREXEL Clinical Pharmacology Research UnitHarrow, United Kingdom | PAREXEL Early Clinical Unit - Los Angeles | PAREXEL Early Phase/California Clinical Trials Medical Group | PAREXEL Early Phase Clinical Uniit, Berlin Germany | PAREXEL Early Phase Clinical Uniit, London | PAREXEL Early Phase Clinical Unit Baltimore | PAREXEL Early Phase Clinical Unit Baltimore, 3001 S. Hanover St., Baltimore, MD 21225, United States of America | Parexel Early Phase Clinical Unit (Baltimore), Harbor Hospital, 3001 S. Hanover St., Baltimore, MD 21225, United States of America (USA) | Parexel Early Phase Clinical Unit Baltimore Harbor Hospital 3001 South Hanover St. Baltimore, MD 21225 USA | Parexel Early Phase Clinical Unit Baltimore (Study Centre) | PAREXEL Early Phase Clinical Unit, Baltimore, United States of America | Parexel Early Phase Clinical Unit Berlin | PAREXEL Early Phase Clinical Unit Berlin | PAREXEL Early Phase Clinical Unit, Berlin | Parexel Early Phase Clinical Unit Berlin Campus DRK Kliniken Berlin Westend, Haus 31 Spandauer Damm 130 14050 Berlin Germany | PAREXEL Early Phase Clinical Unit Berlin, On the premises of Klinikum Westend, Haus 31, Spandauer Damm 130, 14050 Berlin, Germany | PAREXEL Early Phase Clinical Unit, Level 7, Northwick Park Hospital, Watford Road, Harrow, Middlesex, HA1 3UJ, United Kingdom | Parexel Early Phase Clinical Unit London | Parexel Early Phase Clinical Unit (London) | Parexel Early Phase Clinical Unit (LONDON), | PAREXEL Early Phase Clinical Unit London | PAREXEL Early Phase Clinical Unit, London | Parexel Early Phase Clinical Unit London, Level 7, Northwick Park Hospital Watford Road, Harrow Middlesex HA1 3UJ UK | PAREXEL Early Phase Clinical Unit London, Level 7, Northwick Park Hospital, Watford Road, Harrow, Middlesex HA1 3UJ, United Kingdom | Parexel Early Phase Clinical Unit London,Northwick Park Hospital | PAREXEL Early Phase Clinical Unit, London UK. | PAREXEL Early Phase Clinical Unit London, United Kingdom | PAREXEL Early Phase Clinical Unit, London, United Kingdom | PAREXEL Early Phase Clinical Unit-Los Angeles | PAREXEL Early Phase Clinical Unit Los Angeles 1560 Chevy Chase Drive, Suite 140 Glendale, CA 91206 United States of America | Parexel, early phases | Parexel ECPU Baltimore | PAREXEL EPCU | Parexel EPCU (London) | Parexel GmbH | PAREXEL, Harbor Hospital Center, Baltimore, MD 21225 | PAREXEL, Institute for Clinical Pharmacology | Parexel Int. Bloemfontein | PAREXEL International - Baltimore | Parexel International - Baltimore CPRU | Parexel International, Berlin, Germany | PAREXEL International - EPCU Baltimore | PAREXEL International GmbH, Berlin | Parexel International GmbH, Berlin, Germany | PAREXEL International GmbH, Berlin, Germany | Parexel International GmbH, Clinical Pharmacology Research Unit | Parexel International GmbH Early Phase Clinical Unit Berlin | Parexel International GmbH, Early Phase Clinical Unit Berlin | PAREXEL International GmbH, Early Phase Clinical Unit - Berlin | PAREXEL International GmbH EPCU Berlin | Parexel International GmbhH (CRO) | Parexel International Japan | Parexel International Ltd | PAREXEL International Medical Services | PAREXEL Ltd. | PAREXEL (South Africa) | Senior Clinical Research Physician, Parexel Early Phase Clinical Unit London
Highest phase reached
Phase 4
First clinical trial
Nov 2, 1999Last known activity
Jan 28, 2026
Timeline
1980s
- Jan 1, 1982
Parexel— Founded
2000s
- Nov 15, 2006
California Clinical Trials— Acquired
- Jun 13, 2008
ClinPhone, Inc.— Acquired
2010s
- Oct 3, 2014
ClinIntel— Acquired
Drugs by trial phase (424 distinct, 491 trials)
Phase 4 (21 own, 2 via acquisition)
Phase 3 (69 own, 4 via acquisition)
Phase 2 (100 own, 4 via acquisition)
Phase 1 (195 own, 22 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Lung Injury
- Alzheimer Disease
- Anemia
- Anemia, Iron-Deficiency
- Anemia, Sickle Cell
- Angioedema
- Angioedemas, Hereditary
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Atypical Squamous Cells of the Cervix
- Bacterial Infections
- Breast Neoplasms
- Cachexia
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cardiovascular Diseases
- Cognitive Dysfunction
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Communicable Diseases
- Conjunctivitis
- Conjunctivitis, Allergic
- Constipation
- Corneal Neovascularization
- Coronary Artery Disease
- Coronary Disease
- Cough
- Crohn Disease
- Cystadenocarcinoma, Serous
- Cystic Fibrosis
- Deficiency Diseases
- Dementia
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Digestive System Diseases
- Diphtheria
- Dysentery, Bacillary
- Dyslipidemias
- Eczema
- Epilepsies, Partial
- Epilepsy
- Esophagitis
- Esophagitis, Peptic
- Essential Hypertension
- Exocrine Pancreatic Insufficiency
- Familial Primary Pulmonary Hypertension
- Fatty Liver
- Fibrosis
- Gastroenteritis
- Gastroesophageal Reflux
- Gastrointestinal Diseases
- Glomerulonephritis, IGA
- Graft vs Host Disease
- Heartburn
- Heart Failure
- Hematologic Neoplasms
- Hemophilia A
- Hepatitis
- Hepatitis B
- Hepatitis B, Chronic
- Hereditary Angioedema Types I and II
- HIV Infections
- Hypercholesterolemia
- Hypertension
- Hypertension, Pulmonary
- Hypertrophy
- Hyperuricemia
- Idiopathic Pulmonary Fibrosis
- Immunologic Deficiency Syndromes
- Infarction
- Infarction, Middle Cerebral Artery
- Infections
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Kidney Diseases
- Latent Tuberculosis
- Leg Ulcer
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Injury
- Lung Neoplasms
- Lupus Nephritis
- Lymphoma
- Lymphoma, Follicular
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (50)
- NCT04220203CollaboratorN/A—
- NCT07241065CollaboratorPhase 1Jan 28, 2026
- NCT07312851CollaboratorPhase 1Jan 12, 2026
- NCT07290283CollaboratorPhase 1Dec 10, 2025
- NCT07073950CollaboratorPhase 4Nov 14, 2025
- NCT07216131CollaboratorPhase 1Nov 10, 2025
- NCT07064122CollaboratorPhase 1Nov 3, 2025
- NCT07161414CollaboratorPhase 1Oct 21, 2025
- NCT07181161CollaboratorPhase 1/Phase 2Oct 1, 2025
- NCT07060365CollaboratorPhase 1/Phase 2Sep 2, 2025
- NCT06952803CollaboratorPhase 3Aug 6, 2025
- NCT07088913CollaboratorPhase 1Jul 28, 2025
- NCT07069712CollaboratorPhase 2Jul 17, 2025
- NCT06951880CollaboratorPhase 1Jun 27, 2025
- NCT07024823CollaboratorPhase 1Jun 9, 2025
Details
- Founded
- Waltham, Massachusetts, US Jan 1, 1982
- Last known activity
- Jan 28, 2026